Custom crystal celebrating the submission of a New Drug Application (NDA) to the Food and Drug Administration (FDA). The application, related to Impel NeuroPharma’s migraine treatment INP104, was supported by a Phase 3, open-label STOP-301 Trial.
(20ALJ356)Crystal deal toy celebrating the initial public offering by pharmaceutical firm Rua Bioscience. The New Zealand-based company is licensed to produce cannabis-derived medicines.
(20ALJ334)Crystal deal toy, incorporating an interior, 3-D etching of Thor’s hammer, commemorating a private placement by pharmaceutical company Photocure ASA. Based in Oslo, Norway, Photocure specializes in photodynamic therapies that make use of light-activated drugs.
(20LJW163)Crystal deal toy commemorating the acquisition of Philadelphia-based Spark Therapeutics. The acquiring firm, Swiss pharmaceutical firm Roche, is headquartered in Basel.
(9ALJ621)Custom crystal from the Bill and Melinda Gates Foundation recognizing the contributions to the Global Vaccine Summit. The 2020 “Gavi” conference, held virtually due to COVID-19, included 42 heads of state and government.
(20LJW152)Lucite tombstone celebrating a private placement and concurrent global offering of shares by Calliditas Therapeutics. Joint bookrunners in the offering by the Swedish biotech firm were Citi, Jefferies, and Stifel.
(20ALJ348)Crystal financial tombstone commemorating a public offering of common stock by Applied UV. The company’s technology uses narrow-range ultra violet light to prevent infection.
(20AJH232)Lucite deal toy celebrating an investment in GC Rieber VivoMega, a Norwegian supplier of Omega-3 concentrates.
(21LJW034)
